Why Is Bristol Myers Squibb Stock Gaining Monday?

Bristol Myers Squibb & Co. (NYSE:BMY) announced outcomes Monday from two major Phase 3 clinical trials, showcasing significant advancements in treatments for gastroenteropancreatic neuroendocrine tumors and idiopathic pulmonary fibrosis. Following the...